What does this research mean for the field?

Stage-specific modulation of the mitochondria-immune axis, particularly the dynamic interactions between damaged mitochondria and macrophages, represents a promising therapeutic strategy for mitigating myocardial ischemia-reperfusion injury. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the molecular mechanisms underlying dynamic mitochondria–macrophage crosstalk during myocardial ischemia–reperfusion injury and evaluate biomaterial-based targeted delivery platforms for cardiac therapy.

August 27, 2026Journal of NanobiotechnologyOpen Access

Regulatory mechanisms of dynamic mitochondria–macrophage interactions in myocardial ischemia–reperfusion injury and materials-based targeted therapy

View Full Paper

Ask AI

Bookmark

Authors

ZBZongze Bai PQPeng Qu MZMingZhi Zhou

Discussion

Member takes

Overview

Review outlines dynamic mitochondria-macrophage interactions in myocardial ischemia-reperfusion injury, highlighting multistage biomaterials as potential targeted therapeutic strategies.

Key Points

To review the molecular mechanisms underlying dynamic mitochondria–macrophage crosstalk during myocardial ischemia–reperfusion injury and evaluate biomaterial-based targeted delivery platforms for cardiac therapy.
Synthesized evidence on mitochondrial stress, mPTP opening, and cell death pathways including pyroptosis, ferroptosis, and mitoxyperilysis in reperfused myocardium.
Examined myeloid sensing of mitochondrial damage signals (mtDAMPs) and macrophage counter-regulatory mechanisms such as efferocytosis, histone lactylation, and intercellular mitochondrial transfer.
Evaluated environment-responsive, immune-camouflaged, and multistage materials-based delivery systems aimed at modulating the mitochondria–immune axis.
Reperfusion stress prompts mPTP opening and mtDAMP leakage, driving cGAS–STING and NLRP3 inflammasome activation across cardiomyocytes and infiltrating macrophages.
Macrophage responses balance tissue injury and repair via lysosomal clearance, metabolic reprogramming, and intercellular mitochondrial exchange via tunneling nanotubes and extracellular vesicles.
Smart biomaterials offering stage-specific, environmentally responsive drug release improve delivery efficiency and cardiac recovery by selectively targeting the mitochondria–immune microenvironment.

Cite This Study

Bai et al. (2026) studied this question.

synapsesocial.com/papers/6a8fea3310c91c1e9262244b https://doi.org/10.1186/s12951-026-04978-y

View Full Paper

Ask AI

Bookmark

August 27, 2026Journal of NanobiotechnologyOpen Access

Regulatory mechanisms of dynamic mitochondria–macrophage interactions in myocardial ischemia–reperfusion injury and materials-based targeted therapy

View Full Paper

Ask AI

Bookmark

Authors

ZBZongze Bai PQPeng Qu MZMingZhi Zhou

Discussion

Member takes

Overview

Review outlines dynamic mitochondria-macrophage interactions in myocardial ischemia-reperfusion injury, highlighting multistage biomaterials as potential targeted therapeutic strategies.

Key Points

To review the molecular mechanisms underlying dynamic mitochondria–macrophage crosstalk during myocardial ischemia–reperfusion injury and evaluate biomaterial-based targeted delivery platforms for cardiac therapy.
Synthesized evidence on mitochondrial stress, mPTP opening, and cell death pathways including pyroptosis, ferroptosis, and mitoxyperilysis in reperfused myocardium.
Examined myeloid sensing of mitochondrial damage signals (mtDAMPs) and macrophage counter-regulatory mechanisms such as efferocytosis, histone lactylation, and intercellular mitochondrial transfer.
Evaluated environment-responsive, immune-camouflaged, and multistage materials-based delivery systems aimed at modulating the mitochondria–immune axis.
Reperfusion stress prompts mPTP opening and mtDAMP leakage, driving cGAS–STING and NLRP3 inflammasome activation across cardiomyocytes and infiltrating macrophages.
Macrophage responses balance tissue injury and repair via lysosomal clearance, metabolic reprogramming, and intercellular mitochondrial exchange via tunneling nanotubes and extracellular vesicles.
Smart biomaterials offering stage-specific, environmentally responsive drug release improve delivery efficiency and cardiac recovery by selectively targeting the mitochondria–immune microenvironment.

Cite This Study

Bai et al. (2026) studied this question.

synapsesocial.com/papers/6a8fea3310c91c1e9262244b https://doi.org/10.1186/s12951-026-04978-y

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark